Total Payments
$5,021
2024 Payments
$1,299
Companies
24
Transactions
240
Medicare Patients
1,131
Medicare Billing
$79,561
Payment Breakdown by Category
Food & Beverage$4,919 (98.0%)
Education$57.00 (1.1%)
Other$44.76 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,919 | 236 | 98.0% |
| Education | $57.00 | 3 | 1.1% |
| Debt forgiveness | $44.76 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,026 | 42 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $671.02 | 9 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $621.90 | 31 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $443.94 | 34 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $328.26 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $318.07 | 33 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $252.03 | 21 | $0 (2024) |
| ITI, Inc. | $231.98 | 17 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $165.53 | 2 | $0 (2023) |
| Alkermes, Inc. | $165.15 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,299 | 63 | AstraZeneca Pharmaceuticals LP ($253.49) |
| 2023 | $1,680 | 86 | Otsuka America Pharmaceutical, Inc. ($319.25) |
| 2022 | $1,300 | 49 | ABBVIE INC. ($463.11) |
| 2021 | $741.87 | 42 | AbbVie Inc. ($291.59) |
All Payment Transactions
240 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Neuropsychiatry | ||||||
| 12/06/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Central Nervous System | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $65.61 | General |
| Category: CNS | ||||||
| 11/13/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $89.15 | General |
| Category: Neurology | ||||||
| 11/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.61 | General |
| Category: PSYCHIATRY | ||||||
| 11/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.61 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $2.74 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.61 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $2.74 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $23.62 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $6.38 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: PSYCHIATRY | ||||||
| 10/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: PSYCHIATRY | ||||||
| 10/03/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Oncology | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: PSYCHIATRY | ||||||
| 09/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 359 | 528 | $72,643 | $23,617 |
| 2022 | 10 | 276 | 481 | $63,830 | $21,335 |
| 2021 | 11 | 300 | 482 | $61,588 | $21,312 |
| 2020 | 7 | 196 | 335 | $37,084 | $13,297 |
Total Patients
1,131
Total Services
1,826
Medicare Billing
$79,561
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 113 | $28,015 | $8,502 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 134 | $23,997 | $6,741 | 28.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 23 | 23 | $5,980 | $2,477 | 41.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 28 | 53 | $2,835 | $1,896 | 66.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 17 | 17 | $1,445 | $1,223 | 84.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 21 | 22 | $3,850 | $1,053 | 27.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $576.00 | $564.48 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 26 | 50 | $1,750 | $476.00 | 27.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 18 | 25 | $2,115 | $382.52 | 18.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 14 | 15 | $600.00 | $117.60 | 19.6% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 17 | 18 | $630.00 | $109.98 | 17.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 23 | 34 | $850.00 | $74.80 | 8.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 52 | 109 | $23,715 | $7,670 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 125 | $22,131 | $6,179 | 27.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 31 | 31 | $7,695 | $3,432 | 44.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 25 | 65 | $3,085 | $2,198 | 71.3% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 17 | 18 | $3,150 | $551.03 | 17.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 21 | 51 | $1,785 | $488.40 | 27.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 16 | $384.00 | $377.28 | 98.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 18 | 18 | $555.00 | $282.08 | 50.8% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 11 | 13 | $455.00 | $80.03 | 17.6% |
| 81003 | Automated urinalysis test | Office | 2022 | 21 | 35 | $875.00 | $77.83 | 8.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 54 | 112 | $24,890 | $8,593 | 34.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 79 | 136 | $24,212 | $7,103 | 29.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 19 | 19 | $3,135 | $2,147 | 68.5% |
About Kelly Eckes, APRN
Kelly Eckes, APRN is a Family healthcare provider based in Casper, Wyoming. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2017. The National Provider Identifier (NPI) number assigned to this provider is 1932620002.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kelly Eckes, APRN has received a total of $5,021 in payments from pharmaceutical and medical device companies, with $1,299 received in 2024. These payments were reported across 240 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($4,919).
As a Medicare-enrolled provider, Eckes has provided services to 1,131 Medicare beneficiaries, totaling 1,826 services with total Medicare billing of $79,561. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Casper, WY
- Active Since 06/29/2017
- Last Updated 03/27/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1932620002
Products in Payments
- VRAYLAR (Drug) $511.86
- CAPLYTA (Drug) $484.01
- UBRELVY (Drug) $408.17
- REXULTI (Drug) $366.11
- HETLIOZ (Drug) $236.80
- BREZTRI (Drug) $224.93
- AIRSUPRA (Drug) $223.63
- FANAPT (Drug) $207.14
- ABILIFY ASIMTUFII (Drug) $187.59
- TRELEGY ELLIPTA (Drug) $165.80
- QUVIVIQ (Drug) $165.53
- LYBALVI (Drug) $165.15
- UZEDY (Drug) $163.02
- JORNAY PM (Drug) $153.02
- FARXIGA (Drug) $151.76
- Austedo XR (Drug) $141.80
- QULIPTA (Drug) $105.96
- Wegovy (Drug) $99.53
- ABILIFY MAINTENA (Drug) $62.62
- MOUNJARO (Drug) $59.81
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Casper
Mrs. Debra Griner, Fnp-C, FNP-C
Family — Payments: $6,961
Family $6,961
Jamie Mosbrucker
Family — Payments: $4,196
Family $4,196
Dr. Shawn Snyder, Dnp, Aprn, Fnp-C, DNP, APRN, FNP-C
Family — Payments: $3,529
Family $3,529
Tracie Parsell, Fnp, FNP
Family — Payments: $3,350
Family $3,350
Brehan Newell, Aprn, Fnp, APRN, FNP
Family — Payments: $1,777
Family $1,777
Brenda Threlkeld
Family — Payments: $1,770
Family $1,770